Kiadis Pharma N.V.
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
08 jul 2020 - 07:00
Statutory name
Kiadis Pharma N.V.
Title
Kiadis licenses previously undisclosed pre-clinical K-NK-cell programs to Sanofi, with total potential deal value of €875 million, plus royalties
Date last update: 14 October 2026